Home / CellCentric

CellCentric

CellCentric

From a foundation in epigenetics, developing CCS1477, a first-in-class p300/CBP inhibitor to treat specific cancers.

CellCentric

From a foundation in epigenetics, developing CCS1477, a first-in-class p300/CBP inhibitor to treat specific cancers.

Do you work for CellCentric?

Update this profile
Type

preclinical

Number of employees

11-50

avatar

Answer a few questions to help us improve transparency in clinical research

Are you a sponsor who has worked with CellCentric?